+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Drug Testing Market By Drug Type, By Sample Type, By Product Type, By End User, By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • ID: 5387652
  • Report
  • June 2021
  • Region: Global
  • 301 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Omega Laboratories, Inc.
  • Quidel Corporation
The Global Drug Testing Market size is expected to reach $11.7 billion by 2027, rising at a market growth of 5.1% CAGR during the forecast period. Drug testing refers to the process in which a biological sample is used to identify the presence or absence of a drug or its metabolites. This procedure can be done in many kinds of setting and using different techniques. Due to the fact that the body metabolizes different drugs at varied rates, the time period for identifying some drugs or metabolites can be highly specific and can differ extensively from substance to substance. Along with some limitations, drug testing is very crucial in the clinical setting as the patient self-reporting, clinical examination, and collateral reporting are likely to misjudge the real incidence of substance use. Though, drug testing must be accompanied by psychosocial and history/physical assessment.

Various factors like legal cases, probation, divorce, custody, court-ordered testing, and employee testing make it necessary to take a drug test. In addition to it, various global, as well as country-level sporting events require drug screens to know whether athletes have utilized performance-enhancing drugs. There are various kinds of drug tests based on the objective of the test. These involve hair, urine, blood, saliva, and perspiration. The most common testing is urine testing due to its properties like ease, cost-effective and rapid results. It is the sole testing method sanctioned for federally mandated testing. Urine testing is efficient enough to identify whether a substance has been utilized in the last some days for the majority of the drugs.


Several government initiatives with an aim to track and fight with substance abuse are boosting the market. The Substance Use and Addictions Program (SUAP) of Health Canada provide investments and contribute to projects that aim to reduce substance abuse issues in Canada. This initiative addresses substance use prevention, harm reduction, and treatment programs across Canada. In addition to it, in April 2016, the New York City government introduced a broad range of initiatives to train doctors and counselors doing the treatment of substance abuse and rising testing for synthetic opioids. The National Drug Control Budget claimed USD 34.6 billion in FY 2020 across five drug functional aspects in the U.S.: Operation, law enforcement, prevention, treatment, and interdiction.

COVID-19 Impact

COVID-19 has created a major slowdown of the businesses and economic activities around the world and is expected to showcase a short-term adverse impact on the drug testing market because of the low or non-accessibility of medical facilities/treatment centers, harm reduction services vendors, and the fear of transmission of the infection. In order to decrease the burden on the healthcare system and reduce the possibility of virus transmission, several governments around the world offered guidelines to defer or suspend non-essential medical and surgical procedures.

There were strict lockdown guidelines and restrictions on travel, public gatherings, business operations, and shelter-in-place orders, and these aspects have further influenced the growth of the market. Various nations around the world are launching country-wide lockdowns and the temporary shutdowns of industries, manufacturing, business development, and production have been significantly affected. Trade barriers have further adversely impacted the demand-supply gap. Companies working in the drug testing market have faced disturbances in the global supply chain, decreased demand, or discontinuation of operations by their customers.

Drug Type Outlook

Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. The cannabis/marijuana segment garnered the highest revenue share of the drug-testing market in 2020. This massive revenue share of the segment is due to the fact that cannabis or marijuana is the extremely and commonly utilized illicit substance in major markets, thereby developing a massive demand for its testing kits and instruments.

Sample Type Outlook

Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. The urine samples segment emerged as the dominating segment of the drug-testing market by procuring the maximum revenue share in 2020. The segment is expected to display a faster CAGR throughout the forecast period. As urine samples are the highly common sample type to identify the existence of illicit substances and this factor is responsible for the growth of the segment. Though, the growth of the market is expected to be hindered by the fact that adulteration is getting more prevalent in urine samples to generate a false-negative test result.



Product Type Outlook

Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. In 2020, the consumables segment obtained the maximum revenue share of the drug testing market. The growth of the market is expected to be supported by the growing introduction of advanced consumables that offer advanced solutions to bring ease, accuracy, and rapid results in testing.

End User Outlook

Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Workplaces is expected to showcase the fastest growth rate throughout forecast years. This is credited to the increasing utilization of substance abuse screening in pre-employment and random drug tests to create drug-free premises. In addition to it, in case of workplace accidents, drug tests can be utilized to know whether an accident occurred under the influence of drugs, thereby eliminating the responsibility of the owner for damages. Organizations spend above USD 3,750 million on drug testing.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In the Asia Pacific, the market for drug testing is expected to witness new growth avenues during the forecast period due to the increasing demand for substance abuse testing from developing nations like India and China. The demand for drug testing in these economies has been augmented by the increasing cases of substance abuse disorders, deadly road accidents, and drug-associated crimes. Though, the growth of the market is expected to be slowed down by the absence of clear regulations associated with workplace drug testing.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.

Strategies deployed in Drug Testing Market

May-2021: Roche Diagnostics Norway teamed up with Essenlix, a fast-growing startup company. This collaboration aims to implement the iMOST platform to grow patient at-home testing. Customers can do an accurate diagnostic health test on themselves regardless of the place or time, with one drop of body fluid & a smartphone. The all-in-one platform uses one tool to do the test for all sample types that include blood, urine, saliva, swaps, breath, sputum, mucus, and tissues; and also for most assay types.

Feb-2021: Thermo Fisher Scientific came into partnership with Mindray, a leading global developer, manufacturer, and supplier of medical devices. This partnership aims to make available to users two clinical chemistry analyzers in the US and Canada for drug screening in clinical & drug court labs.

Jun-2020: Thermo Fisher Scientific teamed up with Schrödinger, an American life sciences and materials science company. This collaboration aims to integrate Schrödinger’s software platform along with Thermo Fisher’s cryo-EM technology to extend the applicability of structure-based drug discovery to a broader array of targets that cannot be changed to structure prediction through x-ray crystallography.

Oct-2019: Omega Laboratories received DENATRAN accreditation for their 1,300+ sq. meter São Paulo facility, Omega Global Laboratory Services Do Brasil. Earlier, Omega got accreditation to the ISO/IEC 17025 standard for their Brazil laboratory. This accreditation is focused on the analysis of drugs & drug metabolites in hair. In addition, Omega has carried out testing services in the decade for partners & other accredited laboratories in Brazil from the United States headquarters.

Aug-2019: Abbott entered into an agreement with Intoximeters, a consumer services company. This agreement aimed to market Abbott's SoToxa Mobile Test System, a handheld oral fluid roadside testing solution, which swiftly and reliably identifies recent drug usage along with Intoximeters' Alco-Sensor brand breath alcohol-testing products. In addition, the agreement is expected to help law enforcement agencies in their efforts to minimize the case of drugged driving that is among the most serious road safety issue.

Jun-2019: Quidel Corporation received clearance from the United States Food and Drug Administration (FDA) to market the Quidel Triage TOX Drug Screen, 94600. This product is a fluorescence immunoassay for the qualitative testing of the drug presence or metabolites in human urine of up to 9 drug assays. This test is expected to be utilized with Quidel’s Triage MeterPro instrumented system.

May-2018: Omega Laboratories launched the Omega Hair 17-panel drug test, which is the most comprehensive hair test. This product tests for 45 varied substances, enabling safety-sensitive employers to actively meet the rising epidemic of hard drug usage across the world. The new panel is expected to provide the identification of a broader range of drugs of abuse that includes Benzodiazepines, Tramadol, Fentanyl, Barbiturates, and Ketamine.

Jun-2017: Quest Diagnostics came into partnership with Walmart Stores. This partnership aimed to bring Quest's laboratory testing services to 15 Walmart locations in Florida and Texas. The centers is expected to start offering testing services but may expand to involve other basic healthcare services over time.

Scope of the Study

Market Segments covered in the Report:

By Drug Type
  • Cannabis/Marijuana
  • Opioids
  • Cocaine
  • Alcohol
  • Amphetamine & Methamphetamine
  • LSD
  • Others
By Sample Type
  • Urine Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples
By Product Type
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
By End User
  • Drug Testing Laboratories
  • Workplaces
  • Hospitals
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Quest Diagnostics, Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Dragerwerk AG & Co. KGaA
  • Quidel Corporation
  • Omega Laboratories, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Omega Laboratories, Inc.
  • Quidel Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Drug Testing Market, by Drug Type
1.4.2 Global Drug Testing Market, by Sample Type
1.4.3 Global Drug Testing Market, by Product Type
1.4.4 Global Drug Testing Market, by End User
1.4.5 Global Drug Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Drug Testing Market by Drug Type
3.1 Global Cannabis/Marijuana Drug Testing Market by Region
3.2 Global Opioids Drug Testing Market by Region
3.3 Global Cocaine Drug Testing Market by Region
3.4 Global Alcohol Drug Testing Market by Region
3.5 Global Amphetamine & Methamphetamine Drug Testing Market by Region
3.6 Global LSD Drug Testing Market by Region
3.7 Global Other Drug Type Drug Testing Market by Region

Chapter 4. Global Drug Testing Market by Sample Type
4.1 Global Drug Testing Urine Samples Market by Region
4.2 Global Drug Testing Oral Fluid Samples Market by Region
4.3 Global Drug Testing Hair Samples Market by Region
4.4 Global Drug Testing Other Samples Market by Region

Chapter 5. Global Drug Testing Market by Product Type
5.1 Global Consumables Drug Testing Market by Region
5.2 Global Instruments Drug Testing Market by Region
5.3 Global Rapid Testing Devices Drug Testing Market by Region
5.4 Global Services Drug Testing Market by Region

Chapter 6. Global Drug Testing Market by End-use
6.1 Global Drug Testing Laboratories Drug Testing Market by Region
6.2 Global Workplaces Drug Testing Market by Region
6.3 Global Hospitals Drug Testing Market by Region
6.4 Global Others Drug Testing Market by Region

Chapter 7. Global Drug Testing Market by Region
7.1 North America Drug Testing Market
7.1.1 North America Drug Testing Market by Drug Type
7.1.1.1 North America Cannabis/Marijuana Drug Testing Market by Country
7.1.1.2 North America Opioids Drug Testing Market by Country
7.1.1.3 North America Cocaine Drug Testing Market by Country
7.1.1.4 North America Alcohol Drug Testing Market by Country
7.1.1.5 North America Amphetamine & Methamphetamine Drug Testing Market by Country
7.1.1.6 North America LSD Drug Testing Market by Country
7.1.1.7 North America Other Drug Type Drug Testing Market by Country
7.1.2 North America Drug Testing Market by Sample Type
7.1.2.1 North America Drug Testing Urine Samples Market by Country
7.1.2.2 North America Drug Testing Oral Fluid Samples Market by Country
7.1.2.3 North America Drug Testing Hair Samples Market by Country
7.1.2.4 North America Drug Testing Other Samples Market by Country
7.1.3 North America Drug Testing Market by Product Type
7.1.3.1 North America Consumables Drug Testing Market by Country
7.1.3.2 North America Instruments Drug Testing Market by Country
7.1.3.3 North America Rapid Testing Devices Drug Testing Market by Country
7.1.3.4 North America Services Drug Testing Market by Country
7.1.4 North America Drug Testing Market by End-use
7.1.4.1 North America Drug Testing Laboratories Drug Testing Market by Country
7.1.4.2 North America Workplaces Drug Testing Market by Country
7.1.4.3 North America Hospitals Drug Testing Market by Country
7.1.4.4 North America Others Drug Testing Market by Country
7.1.5 North America Drug Testing Market by Country
7.1.5.1 US Drug Testing Market
7.1.5.1.1 US Drug Testing Market by Drug Type
7.1.5.1.2 US Drug Testing Market by Sample Type
7.1.5.1.3 US Drug Testing Market by Product Type
7.1.5.1.4 US Drug Testing Market by End-use
7.1.5.2 Canada Drug Testing Market
7.1.5.2.1 Canada Drug Testing Market by Drug Type
7.1.5.2.2 Canada Drug Testing Market by Sample Type
7.1.5.2.3 Canada Drug Testing Market by Product Type
7.1.5.2.4 Canada Drug Testing Market by End-use
7.1.5.3 Mexico Drug Testing Market
7.1.5.3.1 Mexico Drug Testing Market by Drug Type
7.1.5.3.2 Mexico Drug Testing Market by Sample Type
7.1.5.3.3 Mexico Drug Testing Market by Product Type
7.1.5.3.4 Mexico Drug Testing Market by End-use
7.1.5.4 Rest of North America Drug Testing Market
7.1.5.4.1 Rest of North America Drug Testing Market by Drug Type
7.1.5.4.2 Rest of North America Drug Testing Market by Sample Type
7.1.5.4.3 Rest of North America Drug Testing Market by Product Type
7.1.5.4.4 Rest of North America Drug Testing Market by End-use
7.2 Europe Drug Testing Market
7.2.1 Europe Drug Testing Market by Drug Type
7.2.1.1 Europe Cannabis/Marijuana Drug Testing Market by Country
7.2.1.2 Europe Opioids Drug Testing Market by Country
7.2.1.3 Europe Cocaine Drug Testing Market by Country
7.2.1.4 Europe Alcohol Drug Testing Market by Country
7.2.1.5 Europe Amphetamine & Methamphetamine Drug Testing Market by Country
7.2.1.6 Europe LSD Drug Testing Market by Country
7.2.1.7 Europe Other Drug Type Drug Testing Market by Country
7.2.2 Europe Drug Testing Market by Sample Type
7.2.2.1 Europe Drug Testing Urine Samples Market by Country
7.2.2.2 Europe Drug Testing Oral Fluid Samples Market by Country
7.2.2.3 Europe Drug Testing Hair Samples Market by Country
7.2.2.4 Europe Drug Testing Other Samples Market by Country
7.2.3 Europe Drug Testing Market by Product Type
7.2.3.1 Europe Consumables Drug Testing Market by Country
7.2.3.2 Europe Instruments Drug Testing Market by Country
7.2.3.3 Europe Rapid Testing Devices Drug Testing Market by Country
7.2.3.4 Europe Services Drug Testing Market by Country
7.2.4 Europe Drug Testing Market by End-use
7.2.4.1 Europe Drug Testing Laboratories Drug Testing Market by Country
7.2.4.2 Europe Workplaces Drug Testing Market by Country
7.2.4.3 Europe Hospitals Drug Testing Market by Country
7.2.4.4 Europe Others Drug Testing Market by Country
7.2.5 Europe Drug Testing Market by Country
7.2.5.1 Germany Drug Testing Market
7.2.5.1.1 Germany Drug Testing Market by Drug Type
7.2.5.1.2 Germany Drug Testing Market by Sample Type
7.2.5.1.3 Germany Drug Testing Market by Product Type
7.2.5.1.4 Germany Drug Testing Market by End-use
7.2.5.2 UK Drug Testing Market
7.2.5.2.1 UK Drug Testing Market by Drug Type
7.2.5.2.2 UK Drug Testing Market by Sample Type
7.2.5.2.3 UK Drug Testing Market by Product Type
7.2.5.2.4 UK Drug Testing Market by End-use
7.2.5.3 France Drug Testing Market
7.2.5.3.1 France Drug Testing Market by Drug Type
7.2.5.3.2 France Drug Testing Market by Sample Type
7.2.5.3.3 France Drug Testing Market by Product Type
7.2.5.3.4 France Drug Testing Market by End-use
7.2.5.4 Russia Drug Testing Market
7.2.5.4.1 Russia Drug Testing Market by Drug Type
7.2.5.4.2 Russia Drug Testing Market by Sample Type
7.2.5.4.3 Russia Drug Testing Market by Product Type
7.2.5.4.4 Russia Drug Testing Market by End-use
7.2.5.5 Spain Drug Testing Market
7.2.5.5.1 Spain Drug Testing Market by Drug Type
7.2.5.5.2 Spain Drug Testing Market by Sample Type
7.2.5.5.3 Spain Drug Testing Market by Product Type
7.2.5.5.4 Spain Drug Testing Market by End-use
7.2.5.6 Italy Drug Testing Market
7.2.5.6.1 Italy Drug Testing Market by Drug Type
7.2.5.6.2 Italy Drug Testing Market by Sample Type
7.2.5.6.3 Italy Drug Testing Market by Product Type
7.2.5.6.4 Italy Drug Testing Market by End-use
7.2.5.7 Rest of Europe Drug Testing Market
7.2.5.7.1 Rest of Europe Drug Testing Market by Drug Type
7.2.5.7.2 Rest of Europe Drug Testing Market by Sample Type
7.2.5.7.3 Rest of Europe Drug Testing Market by Product Type
7.2.5.7.4 Rest of Europe Drug Testing Market by End-use
7.3 Asia Pacific Drug Testing Market
7.3.1 Asia Pacific Drug Testing Market by Drug Type
7.3.1.1 Asia Pacific Cannabis/Marijuana Drug Testing Market by Country
7.3.1.2 Asia Pacific Opioids Drug Testing Market by Country
7.3.1.3 Asia Pacific Cocaine Drug Testing Market by Country
7.3.1.4 Asia Pacific Alcohol Drug Testing Market by Country
7.3.1.5 Asia Pacific Amphetamine & Methamphetamine Drug Testing Market by Country
7.3.1.6 Asia Pacific LSD Drug Testing Market by Country
7.3.1.7 Asia Pacific Other Drug Type Drug Testing Market by Country
7.3.2 Asia Pacific Drug Testing Market by Sample Type
7.3.2.1 Asia Pacific Drug Testing Urine Samples Market by Country
7.3.2.2 Asia Pacific Drug Testing Oral Fluid Samples Market by Country
7.3.2.3 Asia Pacific Drug Testing Hair Samples Market by Country
7.3.2.4 Asia Pacific Drug Testing Other Samples Market by Country
7.3.3 Asia Pacific Drug Testing Market by Product Type
7.3.3.1 Asia Pacific Consumables Drug Testing Market by Country
7.3.3.2 Asia Pacific Instruments Drug Testing Market by Country
7.3.3.3 Asia Pacific Rapid Testing Devices Drug Testing Market by Country
7.3.3.4 Asia Pacific Services Drug Testing Market by Country
7.3.4 Asia Pacific Drug Testing Market by End-use
7.3.4.1 Asia Pacific Drug Testing Laboratories Drug Testing Market by Country
7.3.4.2 Asia Pacific Workplaces Drug Testing Market by Country
7.3.4.3 Asia Pacific Hospitals Drug Testing Market by Country
7.3.4.4 Asia Pacific Others Drug Testing Market by Country
7.3.5 Asia Pacific Drug Testing Market by Country
7.3.5.1 China Drug Testing Market
7.3.5.1.1 China Drug Testing Market by Drug Type
7.3.5.1.2 China Drug Testing Market by Sample Type
7.3.5.1.3 China Drug Testing Market by Product Type
7.3.5.1.4 China Drug Testing Market by End-use
7.3.5.2 Japan Drug Testing Market
7.3.5.2.1 Japan Drug Testing Market by Drug Type
7.3.5.2.2 Japan Drug Testing Market by Sample Type
7.3.5.2.3 Japan Drug Testing Market by Product Type
7.3.5.2.4 Japan Drug Testing Market by End-use
7.3.5.3 India Drug Testing Market
7.3.5.3.1 India Drug Testing Market by Drug Type
7.3.5.3.2 India Drug Testing Market by Sample Type
7.3.5.3.3 India Drug Testing Market by Product Type
7.3.5.3.4 India Drug Testing Market by End-use
7.3.5.4 South Korea Drug Testing Market
7.3.5.4.1 South Korea Drug Testing Market by Drug Type
7.3.5.4.2 South Korea Drug Testing Market by Sample Type
7.3.5.4.3 South Korea Drug Testing Market by Product Type
7.3.5.4.4 South Korea Drug Testing Market by End-use
7.3.5.5 Singapore Drug Testing Market
7.3.5.5.1 Singapore Drug Testing Market by Drug Type
7.3.5.5.2 Singapore Drug Testing Market by Sample Type
7.3.5.5.3 Singapore Drug Testing Market by Product Type
7.3.5.5.4 Singapore Drug Testing Market by End-use
7.3.5.6 Malaysia Drug Testing Market
7.3.5.6.1 Malaysia Drug Testing Market by Drug Type
7.3.5.6.2 Malaysia Drug Testing Market by Sample Type
7.3.5.6.3 Malaysia Drug Testing Market by Product Type
7.3.5.6.4 Malaysia Drug Testing Market by End-use
7.3.5.7 Rest of Asia Pacific Drug Testing Market
7.3.5.7.1 Rest of Asia Pacific Drug Testing Market by Drug Type
7.3.5.7.2 Rest of Asia Pacific Drug Testing Market by Sample Type
7.3.5.7.3 Rest of Asia Pacific Drug Testing Market by Product Type
7.3.5.7.4 Rest of Asia Pacific Drug Testing Market by End-use
7.4 LAMEA Drug Testing Market
7.4.1 LAMEA Drug Testing Market by Drug Type
7.4.1.1 LAMEA Cannabis/Marijuana Drug Testing Market by Country
7.4.1.2 LAMEA Opioids Drug Testing Market by Country
7.4.1.3 LAMEA Cocaine Drug Testing Market by Country
7.4.1.4 LAMEA Alcohol Drug Testing Market by Country
7.4.1.5 LAMEA Amphetamine & Methamphetamine Drug Testing Market by Country
7.4.1.6 LAMEA LSD Drug Testing Market by Country
7.4.1.7 LAMEA Other Drug Type Drug Testing Market by Country
7.4.2 LAMEA Drug Testing Market by Sample Type
7.4.2.1 LAMEA Drug Testing Urine Samples Market by Country
7.4.2.2 LAMEA Drug Testing Oral Fluid Samples Market by Country
7.4.2.3 LAMEA Drug Testing Hair Samples Market by Country
7.4.2.4 LAMEA Drug Testing Other Samples Market by Country
7.4.3 LAMEA Drug Testing Market by Product Type
7.4.3.1 LAMEA Consumables Drug Testing Market by Country
7.4.3.2 LAMEA Instruments Drug Testing Market by Country
7.4.3.3 LAMEA Rapid Testing Devices Drug Testing Market by Country
7.4.3.4 LAMEA Services Drug Testing Market by Country
7.4.4 LAMEA Drug Testing Market by End-use
7.4.4.1 LAMEA Drug Testing Laboratories Drug Testing Market by Country
7.4.4.2 LAMEA Workplaces Drug Testing Market by Country
7.4.4.3 LAMEA Hospitals Drug Testing Market by Country
7.4.4.4 LAMEA Others Drug Testing Market by Country
7.4.5 LAMEA Drug Testing Market by Country
7.4.5.1 Brazil Drug Testing Market
7.4.5.1.1 Brazil Drug Testing Market by Drug Type
7.4.5.1.2 Brazil Drug Testing Market by Sample Type
7.4.5.1.3 Brazil Drug Testing Market by Product Type
7.4.5.1.4 Brazil Drug Testing Market by End-use
7.4.5.2 Argentina Drug Testing Market
7.4.5.2.1 Argentina Drug Testing Market by Drug Type
7.4.5.2.2 Argentina Drug Testing Market by Sample Type
7.4.5.2.3 Argentina Drug Testing Market by Product Type
7.4.5.2.4 Argentina Drug Testing Market by End-use
7.4.5.3 UAE Drug Testing Market
7.4.5.3.1 UAE Drug Testing Market by Drug Type
7.4.5.3.2 UAE Drug Testing Market by Sample Type
7.4.5.3.3 UAE Drug Testing Market by Product Type
7.4.5.3.4 UAE Drug Testing Market by End-use
7.4.5.4 Saudi Arabia Drug Testing Market
7.4.5.4.1 Saudi Arabia Drug Testing Market by Drug Type
7.4.5.4.2 Saudi Arabia Drug Testing Market by Sample Type
7.4.5.4.3 Saudi Arabia Drug Testing Market by Product Type
7.4.5.4.4 Saudi Arabia Drug Testing Market by End-use
7.4.5.5 South Africa Drug Testing Market
7.4.5.5.1 South Africa Drug Testing Market by Drug Type
7.4.5.5.2 South Africa Drug Testing Market by Sample Type
7.4.5.5.3 South Africa Drug Testing Market by Product Type
7.4.5.5.4 South Africa Drug Testing Market by End-use
7.4.5.6 Nigeria Drug Testing Market
7.4.5.6.1 Nigeria Drug Testing Market by Drug Type
7.4.5.6.2 Nigeria Drug Testing Market by Sample Type
7.4.5.6.3 Nigeria Drug Testing Market by Product Type
7.4.5.6.4 Nigeria Drug Testing Market by End-use
7.4.5.7 Rest of LAMEA Drug Testing Market
7.4.5.7.1 Rest of LAMEA Drug Testing Market by Drug Type
7.4.5.7.2 Rest of LAMEA Drug Testing Market by Sample Type
7.4.5.7.3 Rest of LAMEA Drug Testing Market by Product Type
7.4.5.7.4 Rest of LAMEA Drug Testing Market by End-use

Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Siemens AG (Siemens Healthineers)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Dragerwerk AG & Co. KGaA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quidel Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials & Approvals:
8.10. Omega Laboratories, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
8.10.2.2 Accreditation:
Note: Product cover images may vary from those shown
  • Quest Diagnostics, Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Dragerwerk AG & Co. KGaA
  • Quidel Corporation
  • Omega Laboratories, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll